(Q40445894)

English

Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. (English)

1 reference

Europe PubMed Central

20 September 2017

vector-borne disease

0 references

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hiroyuki Mizuguchi

9

object named as

Hiroyuki Mizuguchi

1 reference

Europe PubMed Central

20 September 2017

author name string

Md Nasimuzzaman

1

1 reference

Europe PubMed Central

20 September 2017

Masayuki Kuroda

2

1 reference

Europe PubMed Central

20 September 2017

Sumitaka Dohno

3

1 reference

Europe PubMed Central

20 September 2017

Takenobu Yamamoto

4

1 reference

Europe PubMed Central

20 September 2017

Keiji Iwatsuki

5

1 reference

Europe PubMed Central

20 September 2017

Shigenobu Matsuzaki

6

1 reference

Europe PubMed Central

20 September 2017

Rashel Mohammad

7

1 reference

Europe PubMed Central

20 September 2017

Wakako Kumita

8

1 reference

Europe PubMed Central

20 September 2017

Takao Hayakawa

10

1 reference

Europe PubMed Central

20 September 2017

Hiroyuki Nakamura

11

1 reference

Europe PubMed Central

20 September 2017

Takahiro Taguchi

12

1 reference

Europe PubMed Central

20 September 2017

Hiroshi Wakiguchi

13

1 reference

Europe PubMed Central

20 September 2017

Shosuke Imai

14

1 reference

Europe PubMed Central

20 September 2017

publication date

1 April 2005

1 reference

Europe PubMed Central

20 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

20 September 2017

11

1 reference

Europe PubMed Central

20 September 2017

4

1 reference

Europe PubMed Central

20 September 2017

578-590

1 reference

Europe PubMed Central

20 September 2017

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Immortalization of monkey epithelial cells by specific fragments of Epstein–Barr virus DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus-driven gene therapy for EBV-related lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

A simple and efficient method for purification of infectious recombinant adenovirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Complexity of EBV homologous DNA in continous lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Chromosomal localization of the Ox-44 (CD53) leukocyte antigen gene in man and rodents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2004.12.017

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40445894&oldid=2165072626"